WHO ICTRP trial
Trial of different schemes of PM14 alone and in combination with radiotherapy in…
EUCTR2021-001186-20-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2021-001186-20-ES |
|---|---|
| Public title | Trial of different schemes of PM14 alone and in combination with radiotherapy in soft tissue sarcomas and other solid tumors |
| Scientific title | Phase Ib/II multicohort trial of different schemes of PM14 in monotherapy and in combination with radiotherapy in soft tissue sarcomas and other solid tumors - PRIME |
| Primary sponsor | GRUPO ESPAÑOL DE INVESTIGACIÓN EN SARCOMAS |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United States;Spain |
| Conditions | Advanced soft tissue sarcoma and other solid tumors;Therapeutic area: Diseases [C] - Cancer [C04] |
| Interventions | Product Name: PM14 Pharmaceutical Form: Lyophilisate for solution for infusion INN or Proposed INN: PM14 Other descriptive name: PM14 Concentration unit: mg/m2 milligram(s)/square meter Concentration type: equal Concentration number: 1- |
| Registration date | Jun 23, 2021 |
| Target size | 195 |
| Secondary IDs | GEIS-83 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: